NANETS

What NANETS does

NANETS (North American Neuroendocrine Tumor Society) is a non-profit medical society founded in 2007 and headquartered in New York, serving approximately 600 multidisciplinary medical professionals across North America who specialize in the diagnosis, treatment, and research of neuroendocrine tumors (NETs). The society's core offerings include ten-tiered individual memberships ($45-$235 annually), an annual Multidisciplinary NET Medical Symposium (CME-accredited, attracting over 500 attendees), one-day regional NET Education conferences conducted with local cancer centers, monthly virtual programming/webinars, the NETCast podcast series, and a structured mentorship program. NANETS also publishes ten consensus guidelines since 2013 and administers three research grant programs (NCIS, BTSI, NTIG) each valued at $100,000 over two years, awarding a cumulative $1.5 million to 22 researchers since 2009.

NANETS is governed by an elected board of directors and operates with a small staff of approximately 9 employees. Revenue is generated through membership dues, symposium registrations, regional conference fees, and pharmaceutical industry sponsorship for research grants. The society maintains strategic partnerships with Bioscientifica (Endocrine-Related Cancer journal, impact factor 5.678), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for joint PRRT guidelines, Novartis for the NCIS program, the Neuroendocrine Tumor Research Foundation (NETRF), Ipsen Biopharmaceuticals, and the Society of Abdominal Radiology for joint webinars.

The organization's competitive position rests on its concentration of leading NET clinicians, sustained publication of authoritative clinical guidelines, and an integrated ecosystem of education, research funding, mentorship, and journal access. NANETS does not develop proprietary technology products, operates no commercial AI/ML capabilities, and runs on a CiviCRM-based membership platform. Its strategic trajectory is one of steady incremental expansion through regional events, content diversification (podcast, virtual programming), and deeper pharma-funded research programs.

Name

NANETS

Legal name

North American Neuroendocrine Tumor Society

Website

https://nanets.net

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1–10 employees

Short description

NANETS is a non-profit medical society serving approximately 600 multidisciplinary neuroendocrine tumor specialists across North America through memberships, an annual symposium, regional CME conferences, consensus guidelines, research grants, and mentorship programs.

Ownership category

akta.pro rank

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Membership Dues: Annual membership fees ranging from $45 (Student) to $235 (Pharmaceutical Employee) across 10 membership categories including Doctoral, Early Career, Emeritus, Advanced Practice Provider, Allied Health, and others. Membership provides voting rights, reduced conference registration, journal access, grant eligibility, and networking benefits.
2. Annual Symposium Registration: Reduced registration fees for the Annual Multidisciplinary NET Disease Symposium (CME accredited). Non-members pay higher rates; 50% discount offered to Advanced Practice, Allied Health, and Affiliated Health Providers.
3. Journal Partnership Revenue: NANETS entered agreement with Bioscientifica for publication in Endocrine-Related Cancer (ERC) journal. Members receive 25% discount on publication charges (color printing and supplementary data) when publishing in ERC.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

NANETS is a nonprofit medical professional society that serves approximately 600 multidisciplinary healthcare providers treating neuroendocrine tumors (NETs) across North America. The society's core offerings include an annual multidisciplinary symposium, regional conferences, peer-reviewed research grants, consensus clinical practice guidelines, a mentorship program, and continuing medical education content such as podcasts and webinars.

Product overview

NANETS is a multidisciplinary medical society serving approximately 600 NET professionals. Its offerings include membership with 10 categories, the Annual Multidisciplinary NET Medical Symposium (CME-accredited), Regional NET Education programs, the NETCast Podcast Series, Virtual Programming (NETmed webinars), Research Grants (NCIS, BTSI, NTIG at $100,000 each), Consensus Guidelines, Mentorship Program, Abstracts Library, and Early Career development tracks. The society provides educational content and professional development for medical professionals treating neuroendocrine tumor patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Annual Multidisciplinary Symposium
• Regional Conferences
• Peer-Reviewed Research Grants
• Consensus Clinical Practice Guidelines
• Mentorship Program
• Continuing Medical Education (Podcasts and Webinars)

Quantifiable outcome

• 40,000+ unique users access Endocrine-Related Cancer journal annually
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core and minor.

• Bioscientifica / Endocrine-Related Cancer JournalcoreStrategic or Co-development PartnerNANETS entered into agreement with Bioscientifica for publication of its research work in Endocrine-Related Cancer (ERC) journal - a premier global forum for basic, translational and clinical research on hormones and cancers. ERC has over 40,000 unique users and 5.678 impact factor. ERC is official flagship journal of Society for Endocrinology, endorsed by European Society of Endocrinology, Japanese Hormones and Cancer Society, and Endocrine Society of Australia.
• Society of Nuclear Medicine and Molecular Imaging (SNMMI)coreStrategic or Co-development PartnerCollaborative partnership for PRRT (Peptide Receptor Radionuclide Therapy) guidelines development and publication. Published joint consensus statement on patient selection and appropriate use of 177Lu-DOTATATE. Second collaborative publication published in Journal of Nuclear Medicine. Joint webinar on PRRT with over 200 attendees.
• Pancreas JournalcoreStrategic or Co-development PartnerNANETS' official affiliated medical journal published by Lippincott Williams & Wilkins. Published multiple consensus guidelines including surgical pNETs guidelines, pheochromocytoma/paraganglioma guidelines, and high grade NET guidelines in Pancreas journal.
• NorCal CarciNET CommunityminorStrategic or Co-development PartnerPatient advocacy organization president Josh Mailman is longtime NANETS member and featured speaker. NorCal CarciNET supports NANETS by providing scholarships to medical professionals to attend national conferences.
• Society of Abdominal Radiology (SAR)minorStrategic or Co-development PartnerJoint webinar series collaboration on Abdominal Radiology: Imaging 101 presented by NANETS with SAR. Accredited CME program.
• Collaboration Portal PartnersminorStrategic or Co-development PartnerNANETS launched a collaboration portal to facilitate inquiries for organizations seeking to partner with NANETS. Projects Review Committee reviews all submissions.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• European Neuroendocrine Tumor Society (ENETS): The leading European multidisciplinary NET society, structurally identical to NANETS in mission (consensus guidelines, annual symposiums, research grants, multidisciplinary education), serving as NANETS' closest international counterpart.
• Neuroendocrine Tumor Research Foundation (NETRF): A NET-dedicated nonprofit that co-funds NANETS' BTSI research grants and runs complementary research and patient programs, making it both a partner and a closely overlapping mission peer.
• Carcinoid Cancer Foundation: A long-standing NET-focused nonprofit organization providing patient education and advocacy; overlapping disease focus with NANETS but oriented to patients rather than medical professionals.

Broad incumbents

• European Society for Medical Oncology (ESMO): Europe's leading oncology professional society; offers NET-specific guidelines, congress sessions, and educational content that compete with NANETS' programming at a global scale.
• Society for Endocrinology: A UK-based endocrinology society that publishes the Endocrine-Related Cancer journal — NANETS' official journal partner — making it both an adjacent society and a publishing ecosystem peer.
• Endocrine Society: A major endocrinology-focused professional society with broader scope than NANETS; relevant because NETs are endocrine-origin tumors and overlap exists in physician membership and educational content.
• American Society of Clinical Oncology (ASCO): The dominant U.S. professional society for oncology; offers broad NET programming at massive scale and competes for the same pharmaceutical sponsorship and CME-attending membership that NANETS serves.
• Society of Nuclear Medicine and Molecular Imaging (SNMMI): A larger medical society in nuclear medicine and molecular imaging; NANETS has an active co-publication partnership with SNMMI on PRRT guidelines, making it both an adjacent society and a strategic collaborator.
• American Association for Cancer Research (AACR): A large cancer research society that publishes high-impact journals (e.g., Cancer Discovery) and runs major conferences; competes with NANETS for NET research visibility and pharmaceutical research grants.

Regional players

• American Thyroid Association: A U.S. specialty society in thyroid disease — a closely related endocrine organ system — providing a structural peer for how small, focused medical societies operate member-based education, guidelines, and annual meetings.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/nanets1
• Facebookfacebook.com/NANETS
• LinkedInlinkedin.com/company/nanets

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NANETS